Anixa is pioneering a new approach to preventing the truly aggressive triple-negative form of breast cancer. Based on research from Cleveland Clinic, this approach has the potential to treat other breast cancers as well as ovarian cancer. Dr. Amit Kumar is the President & CEO. More information is available at anixa.com.

Dr. George Yancopoulosis is the President and Chief Scientific Officer of Regeneron. Regeneron is successful on many levels but is perhaps best known for its Covid treatment, directly infusing antibodies. This, of course, requires innovative science … but how do get students to become scientists? Dr. Yancopoulos has an answer.

Alzheimer’s, Parkinson’s dementia, and other neurodegenerative diseases continue to be challenging, but now new science has led to a better understanding of the natural repair mechanisms in the brain. This, in turn, has generated new options for innovative treatments, and one such approach has entered late-stage human clinical trials. Dr. Mark Litton is the President and CEO of Athira Pharma.

On this week’s Tech Nation, Moira speaks with

it’s all about data – who’s collecting it, and why, and how it can serve us, and maybe not. Lee Omar from Red Ninja talks about smart cities around the world, and the art of listening before you build. Tech Nation Health Chief Correspondent Daniel Kraft shows us we can crowdsource medical questions, while Tech Nation Regular Contributor Gary Davis reminds us that we love free stuff, and we pay for it with our data. Then Krishnan Nandabalan, the CEO of InveniAI sees continued value in the data used for drug approval after the drug is approved.

On this week’s Tech Nation, Moira speaks with

USF professor and development economist Bruce Wydick about “Shrewd Samaritan - Faith, Economics, and the Road to Loving Our Global Neighbor”. Which poverty intervention programs work, and which don’t?

Then the global health challenge of the bacteria H. Pylori and its role in stomach ulcers and gastric cancer. Gilead Raday, COO of RedHill Biopharma talks about a treatment in their pipeline and a plan on how to avoid creating antibiotic resistance.

On this week’s Tech Nation, Moira speaks with

UC San Francisco professor Dr. Louise Aronson talks about a new stage of life: Elderhood, – Redefining Aging, Transforming Medicine, Reimaging Life. With modern technology, it lasts longer than anyone imagined.

Also, Tech Nation Health Chief Correspondent Daniel Kraft talks about the Internet of Medical Things, while Dr. Crystal Icenhour, the CEO of Aperiomics, talks about identifying hard-to-diagnose medical conditions by looking at the DNA of microorganisms in your body.

On this week’s Tech Nation, Moira speaks with

the committed people who lead the biotech industry. Physician-entrepreneur Dr. Jeremy Levin chairs BIO, the Biotechnology Innovation Organization, and also works on the rare disease Angelman Syndrome at Ovid Therapeutics. Jim Greenwood, the CEO of BIO, asks “What’s the right thing to do?” about the price of drugs and everyday people. While BIO Vice Chair, Paul Hastings, is also the CEO of Nkarta Therapeutics. With Senior Vice President, Nadir Mahmood, they’re working with Natural Killer cells to fight cancer.

On this week’s Tech Nation, Moira speaks with Tech Nation’s former biotech correspondent David Ewing Duncan about his new book - “Talking to Robots: Tales from Our Human Robot Future.” Then Dr. Daniel Kraft tells us how robotics are replacing surgeons, and McAfee’s Gary Davis, expands on those massive thefts of online credentials – they are for sale and they are out there … on the Dark Web – yes, he explains that, too.

On this week’s Tech Nation, Moira speaks with the people who predict the weather - Todd Hutchinson, the Director of Numerical Weather Prediction at The Weather Company, and Cameron Clayton, the General Manager of Watson Media & Weather. And another question – what’s in the food we eat? And where did it come from? Moira speaks with Brigid McDermott, Vice President of IBM Food Trust. From one field to one processor to one supermarket, technology can keep tiny problems tiny.